Apr
01
2020
Cuban Interferon used against COVID-19.
(CIGB) The human Recombinant Interferon alfa-2B, developed in 1986 by a team of researchers from the Center for Genetic Engineering and Biotechnology (CIGB in its Spanish acronym), has benefitted thousands of Cuban patients since its inception in the Cuban health system more than three decades ago, and is one of the medicines being currently used to combat the novel coronavirus COVID-19.
